XML 31 R18.htm IDEA: XBRL DOCUMENT v3.25.3
Note 12 - Stock-based Compensation
3 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

(12) Stock-Based Compensation

 

We have granted equity incentives to employees and directors in the form of stock options and restricted stock awards. The total stock-based compensation expense for all equity incentives was $304 thousand and $216 thousand for the three months ended September 30, 2025, and September 30, 2024, respectively. 

 

Stock Options

 

The Company’s stock option activity for the three months ended September 30, 2025, is as follows:

 

  Shares  Weighted Average Exercise Price 

Outstanding at June 30, 2025

  213,113  $12.35 

Granted

  62,750   4.73 

Exercised

      

Canceled or expired

  (401)  10.96 

Outstanding at September 30, 2025

  275,462  $10.61 

 

The aggregate intrinsic value was $0 for all of options exercisable and for all unvested options at September 30, 2025, because the fair value of the Company’s common stock was less than the exercise prices of these options.

 

The table below details the Company’s stock options outstanding as of September 30, 2025:

 

 Range of exercise prices  Number Outstanding  Options Outstanding Weighted-Average Remaining Contractual Life (Years)  Weighted-Average Exercise Price  Number Exercisable  Options Exercisable Weighted-Average Exercise Price 
 $4.73 - 9.69   117,750   9.57  $5.99   6,319  $9.42 
 $10.10 - 11.27   79,480   7.98   10.12   52,990   10.12 
 $11.51 - 19.2   76,291   7.97   14.21   46,123   15.96 
 $159 - 175.50   1,941   1.86   170.33   1,941   170.33 
 $4.73 - 175.50   275,462   8.62   10.61   107,373  $15.49 

 

Compensation costs recognized related to stock option awards were $229 thousand and $155 thousand for each of the three months ended September 30, 2025, and 2024, respectively.  The remaining stock-based compensation expense of $1 million related to stock options will be recognized over a weighted-average period of 2.07 years.

 

Restricted Stock

 

The Company’s restricted stock activity for the three months ended September 30, 2025, is as follows:

 

  Shares  Weighted Average Grant Date Fair Value 
Outstanding at June 30, 2025  85,834  $14.11 
Granted      

Vested

  (3,334)  10.10 

Canceled or expired

      
Outstanding at September 30, 2025  82,500  $17.32 

 

Stock compensation expenses related to restricted stock were $75 thousand and $26 thousand for the three months ended September 30, 2025, and 2024, respectively. The remaining stock-based compensation expense of $565 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 2.14 years.